HIF1A and colonic neoplasm: Expression of the cellular prion protein (PrPc) was shown to be enhanced by HIF1α under hypoxia and to mediate TRAIL resistance in colon cancer cells in vitro and in vivo and may involve enhanced Akt and Bcl-2 activity (112).